With its Vivalytic analysis platform, Bosch has set itself the goal of making fast and highly precise diagnostics accessible at the point of care. To achieve this, Bosch has now agreed on a strategic partnership with Randox Laboratories Ltd.

Revolutionary genomic research applied an innovative use of multiomics and biomimetic digital twins to unveil new DNA variants associated with the development of endometrial related disorders.

Antibodies validated for use with bio-Rad’s Celselect slides™ enumeration stain kits to enable immunostaining of captured circulating tumor cells in liquid biopsy samples.

Sino Biological and Rapid Novor partner to offer combined antibody development and sequencing services.

InSphero's Liver Disease team has published a groundbreaking peer-reviewed paper in Nature's Scientific Reports, challenging the limitations of in vitro models in MASH Drug Discovery.

Diasorin announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the company’s new LIAISON PLEX^® platform as well as its first panel of tests, the LIAISON PLEX^® Respiratory Flex Assay.

Aptamer Group plc announces the second phase of its on-going partnership with Neuro-Bio to develop Optimer binders for a lateral flow test for the early diagnosis of Alzheimer’s disease.

Rapid development and clinical validation of diagnostics that enable innovative clinical care pathways in complex, chronic diseases.

High accuracy and detection to identify tumor variants from degraded and low input samples as well as samples with limited DNA abundance. Library preparation kit adds to Twist’s portfolio of tools to enable liquid biopsy applications

Tecan is announcing a streamlined solution portfolio to enable liquid biopsy applications, from upstream workflows to downstream analysis for genomics and proteomics applications.